Literature DB >> 16897363

Giant cells: contradiction to two-hit model of tuber formation?

Jaroslaw Jozwiak1, Sergiusz Jozwiak.   

Abstract

Tuberous sclerosis (TSC) is an autosomal dominant disease characterized by the formation of hamartomatous lesions in many organs, including brain, heart or kidneys. It has been found that TSC is caused by the mutation in one of the two tumor suppressor genes: TSC1 or TSC2, encoding hamartin and tuberin, respectively. According to Knudson's two-hit model of tumorigenesis, second-hit mutation and resulting loss of heterozygosity (LOH) of a tumor suppressor gene is necessary for tumor formation. In fact, LOH is commonly found in several types of hamartomas formed in the process of tuberous sclerosis, but, interestingly, not in brain lesions, containing characteristic giant cells. In this paper, we review literature covering origination of giant cells and present several hypotheses explaining why in spite of the presence of hamartin and tuberin, brain lesions form in TSC patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16897363     DOI: 10.1007/s10571-006-9106-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  66 in total

1.  Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling.

Authors:  Ken Inoki; Yong Li; Tian Xu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2003-07-17       Impact factor: 11.361

2.  Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis.

Authors:  J Kwiatkowska; J Wigowska-Sowinska; D Napierala; R Slomski; D J Kwiatkowski
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

3.  Hepatic angiomyolipoma: a clinicopathologic study of 10 cases.

Authors:  Y Ji; X Zhu; J Xu; J Zhou; Y Tan; J Wang; J Fan; Y Zhou
Journal:  Chin Med J (Engl)       Date:  2001-03       Impact factor: 2.628

4.  Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.

Authors:  S L Dabora; S Jozwiak; D N Franz; P S Roberts; A Nieto; J Chung; Y S Choy; M P Reeve; E Thiele; J C Egelhoff; J Kasprzyk-Obara; D Domanska-Pakiela; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  2000-12-08       Impact factor: 11.025

5.  Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.

Authors:  K A Gyure; R A Prayson
Journal:  Mod Pathol       Date:  1997-04       Impact factor: 7.842

6.  Abnormal cortical cells and astrocytomas in the Eker rat model of tuberous sclerosis complex.

Authors:  D Koji Takahashi; Matthew T Dinday; Nicholas M Barbaro; Scott C Baraban
Journal:  Epilepsia       Date:  2004-12       Impact factor: 5.864

Review 7.  Aspects of tuberous sclerosis complex (TSC) protein function in the brain.

Authors:  V Ramesh
Journal:  Biochem Soc Trans       Date:  2003-06       Impact factor: 5.407

8.  Differential localization of hamartin and tuberin and increased S6 phosphorylation in a tuber.

Authors:  F E Jansen; R G E Notenboom; M Nellist; M A Goedbloed; D J Halley; P N E de Graan; O van Nieuwenhuizen
Journal:  Neurology       Date:  2004-10-12       Impact factor: 9.910

9.  Transient expression of doublecortin during adult neurogenesis.

Authors:  Jason P Brown; Sébastien Couillard-Després; Christiana M Cooper-Kuhn; Jürgen Winkler; Ludwig Aigner; H Georg Kuhn
Journal:  J Comp Neurol       Date:  2003-12-01       Impact factor: 3.215

10.  Subependymal giant cell astrocytoma with cranial and spinal metastases in a patient with tuberous sclerosis. Case report.

Authors:  Albert E Telfeian; Alex Judkins; Donald Younkin; Avrum N Pollock; Peter Crino
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

View more
  4 in total

1.  Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.

Authors:  June Goto; Delia M Talos; Peter Klein; Wei Qin; Yvonne I Chekaluk; Stefanie Anderl; Izabela A Malinowska; Alessia Di Nardo; Roderick T Bronson; Jennifer A Chan; Harry V Vinters; Steven G Kernie; Frances E Jensen; Mustafa Sahin; David J Kwiatkowski
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

2.  Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events.

Authors:  Wei Qin; Jennifer A Chan; Harry V Vinters; Gary W Mathern; David N Franz; Bruce E Taillon; Pascal Bouffard; David J Kwiatkowski
Journal:  Brain Pathol       Date:  2010-07-13       Impact factor: 6.508

3.  Metabolomic studies identify changes in transmethylation and polyamine metabolism in a brain-specific mouse model of tuberous sclerosis complex.

Authors:  James McKenna; David Kapfhamer; Jason M Kinchen; Brandi Wasek; Matthew Dunworth; Tracy Murray-Stewart; Teodoro Bottiglieri; Robert A Casero; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2018-06-15       Impact factor: 6.150

4.  Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.

Authors:  Sharon W Way; James McKenna; Ulrike Mietzsch; R Michelle Reith; Henry Cheng-Ju Wu; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2009-01-15       Impact factor: 6.150

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.